Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 23;14(10):2569.
doi: 10.3390/cancers14102569.

Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)

Affiliations
Review

Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)

Beata Smolarz et al. Cancers (Basel). .

Abstract

Breast cancer is the most-commonly diagnosed malignant tumor in women in the world, as well as the first cause of death from malignant tumors. The incidence of breast cancer is constantly increasing in all regions of the world. For this reason, despite the progress in its detection and treatment, which translates into improved mortality rates, it seems necessary to look for new therapeutic methods, and predictive and prognostic factors. Treatment strategies vary depending on the molecular subtype. Breast cancer treatment is multidisciplinary; it includes approaches to locoregional therapy (surgery and radiation therapy) and systemic therapy. Systemic therapies include hormone therapy for hormone-positive disease, chemotherapy, anti-HER2 therapy for HER2-positive disease, and quite recently, immunotherapy. Triple negative breast cancer is responsible for more than 15-20% of all breast cancers. It is of particular research interest as it presents a therapeutic challenge, mainly due to its low response to treatment and its highly invasive nature. Future therapeutic concepts for breast cancer aim to individualize therapy and de-escalate and escalate treatment based on cancer biology and early response to therapy. The article presents a review of the literature on breast carcinoma-a disease affecting women in the world.

Keywords: breast cancer; pathomorphology; risk factors; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Nardin S., Mora E., Varughese F.M., D’Avanzo F., Vachanaram A.R., Rossi V., Saggia C., Rubinelli S., Gennari A. Breast Cancer Survivorship, Quality of Life, and Late Toxicities. Front. Oncol. 2020;16:864. doi: 10.3389/fonc.2020.00864. - DOI - PMC - PubMed
    1. “Global Cancer Observatory” International Agency for Research on Cancer, Lyon, France. [(accessed on 1 June 2020)]. Available online: https://gco.iarc.fr/
    1. Bellanger M., Zeinomar N., Tehranifar P., Terry M.B. Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? J. Glob. Oncol. 2018;4:1–16. doi: 10.1200/JGO.17.00207. - DOI - PMC - PubMed
    1. Elmore J.G., Armstrong K., Lehman C.D., Fletcher S.W. Screening for breast cancer. JAMA. 2005;293:1245–1256. doi: 10.1001/jama.293.10.1245. - DOI - PMC - PubMed
    1. Francies F.Z., Hull R., Khanyile R., Dlamini Z. Breast cancer in low-middle income countries: Abnormality in splicing and lack of targeted treatment options. Am. J. Cancer Res. 2020;10:1568–1591. - PMC - PubMed